Coverage
-
September 29, 2011
AstraZeneca Pharmaceuticals Inc. announced Thursday that it had reached a settlement with rival Handa Pharmaceuticals LLC in several suits in New Jersey over Handa's bid to produce a generic version of the schizophrenia drug Seroquel XR.
1 other articles on this case.
View all »